To study the effectiveness of psychological therapy in patients with schizophrenia
- Conditions
- Health Condition 1: F20- Schizophrenia
- Registration Number
- CTRI/2019/02/017658
- Lead Sponsor
- Dr B Ravishankar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
1.primary diagnosis of schizophrenia confirmed by Mini International Neuropsychiatric Interview (M.I.N.I), supplemented by DSM-V and clinical diagnosis.
2.participants should have at least 8 years of education
3.participants should have provided informed consent
4.participants should be able to read and speak Tamil language
5.all participant should be symptomatically stable at the time of enrollment,
6.Positive and Negative Syndrome Scale (PANSS) scores should be under 75, ratings of 3 (mild) or less on the PANSS psychosis items.
1.any co-morbid psychiatric disorder, neurological disorders
2.history of substance or alcohol, formal thought disorder, aggressive behavior
3.IQ <70
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Outcome Name: <br/ ><br>â?¢Score on Positive and Negative Symptom Scale (PANSS) <br/ ><br>Expected Outcome: <br/ ><br>â?¢The experimentalintervention group is expected to show 40% reduction in the PANSS score whereas the control or the treatment as usual group is expected to show 10% reduction in the PANSS score. <br/ ><br>Timepoint: After 2 weeks, 6 months and 1 year of completion of intervention
- Secondary Outcome Measures
Name Time Method â?¢To study the effect of metacognitive therapy on patientâ??s insight <br/ ><br>â?¢To study the relationship of positive symptom(as assessed by PANSS)and insight <br/ ><br>â?¢To study the effect of metacognitive therapy on the patientâ??s beliefs <br/ ><br>â?¢To study if the metacognitive therapy improves patientâ??s metacognitive functioning <br/ ><br>â?¢To study if effect of metacognitive therapy on patientâ??s functioningTimepoint: 2 weeks, 6 months and one year after the intervention termination.